CG Invites Co., Ltd. (KOSDAQ:083790)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Invest	1.59B	863.08M	597.83M	7.86B	-
Invest Growth	84.73%	44.37%	-92.40%	-	-
Pharmaceutical Research	17.41B	18.27B	17.61B	9.81B	-
Pharmaceutical Research Growth	-4.70%	3.78%	79.39%	-	-
Other	1.58B	9.41B	18.89B	14.81B	-
Other Growth	-83.20%	-50.17%	27.54%	-	-
Inter-Sectoral Coordination	-13.33B	-14.26B	-14.45B	-6.58B	-
Discontinued Business	-	-27.69B	-34.32B	-	-
Pharmaceutical Manufacturing (Discontinued Business)	-	18.28B	16.00B	-	-
Pharmaceutical Manufacturing (Discontinued Business) Growth	-	14.23%	-	-	-
Pharmaceutical Manufacturing	-	-	-	16.47B	-
Biotechnology	-	-	-	-	30.22B
Biotechnology Growth	-	-	-	-	115.78%
Total	7.25B	4.88B	4.32B	42.38B	30.22B
Total Growth	48.67%	12.90%	-89.80%	40.21%	115.78%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	7.25B	4.28B	4.30B	42.31B	29.48B
South Korea Growth	69.41%	-0.45%	-89.83%	43.51%	111.40%
Overseas	-	597.27M	20.40M	70.72M	745.29M
Overseas Growth	-	2827.48%	-71.15%	-90.51%	1098.81%
Total	7.25B	4.88B	4.32B	42.38B	30.22B
Total Growth	48.67%	12.90%	-89.80%	40.21%	115.78%

Source: S&P Global Market Intelligence.